The Risk Of Blood Clots From The Pill Is Over 2,000 Times Higher Than The J&J Vaccine. Why Is The FDA Rushing To Pause The Vaccine?

On Tuesday, it was reported that the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced Tuesday morning that they are recommending a pause in the administration of the Johnson & Johnson COVID-19 vaccine out of an “abundance of caution.”

“According to released statements, officials are examining whether the vaccine was linked to six cases in the U.S. ‘of a rare & severe type of blood clot.’ The one-shot Johnson & Johnson vaccine has been administered more than 6.8 million times across the country,” wrote the Daily Wire.